ChEMBL logo

ChEMBL

spacer
ChEMBL Statistics
  Loading Statistics...
spacer

Compound Report Card

Compound Name and Classification

Compound ID CHEMBL1201833
CHEMBL1201833
Compound Name GOLIMUMAB
ChEMBL Synonyms Golimumab | L04AB06 | Simponi | CNTO-148
Max Phase 4 (Approved)
Trade Names Simponi

Mechanism of Action

Mechanism of Action ChEMBL Target References
TNF-alpha inhibitor TNF-alpha DailyMed

Molecule Features

CHEMBL1201833 compound icon
Drug Type:mAB Rule of Five:N First In Class:N Chirality:Single Stereoisomer Prodrug:N Oral:N Parenteral:Y Topical:N Black Box:Y Availability Type:Prescription-only

Clinical Data

Number of clinical trials registered at clinicaltrials.gov
Number of reviews at The Cochrane Collaboration
Number of entries at British National Formulary

Compound Cross References

ATC L - ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 - IMMUNOSUPPRESSANTS
L04A - IMMUNOSUPPRESSANTS
L04AB - Tumor necrosis factor alpha (TNF-a) inhibitors
L04AB06 - golimumab

ChemSpider ChemSpider Identifier not yet assigned
DailyMed golimumab
Wikipedia Golimumab
spacer
spacer